- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07408167
AI-modeller i klinisk patologidiagnostik: En multicenter RCT
AI-modellers prestanda i den kliniska patologiska diagnostiska arbetsprocessen: En multicenter, prospektiv, randomiserad kontrollerad studie
The investigators plan to conduct a multicenter, prospective, randomized controlled trial to systematically evaluate the incremental value of pathology-based artificial intelligence (AI) models in a pan-disease diagnostic workflow. The study will primarily compare interpretation using an AI-assisted platform with conventional independent slide reading in terms of diagnostic accuracy (e.g., AUC), reading efficiency (e.g., diagnostic time), diagnostic report quality, diagnostic confidence (Likert scale), and pathologists' satisfaction with the AI model. Investigators will also assess superiority among less experienced (junior) pathologists and non-inferiority among more experienced (senior) pathologists. Successful completion of this project will provide high-level prospective evidence to support standardized deployment, quality control, and broader implementation of pathology AI in clinical practice. This trial may also evaluate the potential benefits and risks of using AI tools in medical research.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
In this study, investigators plan to enroll 60 pathologists with varying levels of experience and 2,000 patients requiring pathological diagnosis, with whole-slide images (WSIs) collected.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Zhengyu Zhang
- Telefonnummer: 13837365993
- E-post: zzyusmu@163.com
Studieorter
-
-
Chongqing Municipality
-
Chongqing, Chongqing Municipality, Kina
- Har inte rekryterat ännu
- The First Hospital Affiliated to AMU SOUTHWEST HOSPITAL
-
Kontakt:
- Xiaohong Yao
- Telefonnummer: 17720466296
- E-post: yxh15@163.com
-
-
Guangdong
-
Guangzhou, Guangdong, Kina, China 510515
- Rekrytering
- Nanfang Hospital, Southern Medical University
-
Kontakt:
- Li Liang
- Telefonnummer: +8615989146266
- E-post: lli@smu.edu.cn
-
Kontakt:
- Zhengyu Zhang
- E-post: zzyusmu@163.com
-
-
Henan
-
Zhengzhou, Henan, Kina
- Har inte rekryterat ännu
- The First Affiliated Hospital of Zhengzhou University
-
Kontakt:
- Shenglei Li
- Telefonnummer: 13598423254
- E-post: 13598423254@126.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Pathologists:
Inclusion Criteria:
- Voluntarily provide written informed consent.
- Age ≥ 20 years.
- Have completed at least 1 year of training in pathological diagnosis.
Exclusion Criteria:
- Individuals with reading difficulties or a reading disorder.
- Unwilling to participate in this study.
Patients:
Inclusion Criteria:
- Voluntarily provide written informed consent.
- Age ≥ 18 years.
- Have available digital pathology images and relevant clinical information.
Exclusion Criteria:
- Missing data or data quality not meeting the requirements for analysis.
- Deemed unsuitable for participation by the investigator.
- Unwilling to participate in this study.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: Randomiserad
- Interventionsmodell: Crossover tilldelning
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: AI-assisted group
Pathologists in this group are required to use the AI pathology diagnostic model to assist their diagnoses. The AI pathology model will provide a predicted result for each case. |
Doctors in this group are required to use the AI model to assist their diagnoses. The AI pathology model will provide a predicted result for each case. |
|
Placebo-jämförare: Independent Diagnosis Group (Control Group)
In this group, pathologists will independently diagnose each case based on their own clinical experience, and will record both their time to diagnosis and their diagnostic confidence. |
Pathologists will independently diagnose each case based on their own clinical experience, and will record both their time to diagnosis and their diagnostic confidence. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Area under ROC curve (AUC)
Tidsram: Assessments will be conducted within one week after the pathologists' diagnoses
|
Area under the curve |
Assessments will be conducted within one week after the pathologists' diagnoses
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Diagnostic time per case
Tidsram: Measured immediately after the pathologists' diagnosis
|
Time required for the pathologist to complete the diagnosis of each case in the AI-assisted diagnosis group compared with the independent diagnosis group. Diagnostic time is defined as the duration (in minutes/seconds) from initiating case review to finalizing and submitting the diagnostic report in the study system. |
Measured immediately after the pathologists' diagnosis
|
|
Pathologists' diagnostic confidence
Tidsram: At the time of diagnosis for each case.
|
Self-reported diagnostic confidence of pathologists for each case in the AI-assisted diagnosis group compared with the independent diagnosis group. Diagnostic confidence will be rated by the reporting pathologist on a [10]-point Likert scale (e.g., 1 = very uncertain to 10 = very confident) immediately after completing the diagnosis. Higher scores indicate greater diagnostic confidence. |
At the time of diagnosis for each case.
|
Samarbetspartners och utredare
Utredare
- Studiestol: Li Liang, Nanfang Hospital, Southern Medical University
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- NFEC-2026-059
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .